News & Updates
Filter by Specialty:
STEMI criteria show similar accuracy in right BBB, non-BBB patients
The ECG criteria used for identifying patients with ST-elevation myocardial infarction (STEMI) demonstrates similar diagnostic accuracy in right bundle branch block (BBB) and non-BBB patients, according to a study.
STEMI criteria show similar accuracy in right BBB, non-BBB patients
27 Aug 2024
Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
A screen-and-prevent strategy for preterm preeclampsia (PE), which involves screening in the first trimester and low-dose aspirin prophylaxis for high-risk women in <16–36 weeks of gestation, will be launched in obstetric units of public hospitals across Hong Kong following promising results from a multicentre Asian trial led by the Chinese University of Hong Kong (CUHK) and a pilot programme at the Prince of Wales Hospital (PWH).
Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success
27 Aug 2024
Anti-inflammatory diet supports brain health in people with cardiometabolic diseases
Among people with cardiometabolic diseases (CMD), diets with lower inflammatory potential contribute to larger gray matter and smaller white matter hyperintensity volumes, as well as reduced risk of dementia, according to a study.
Anti-inflammatory diet supports brain health in people with cardiometabolic diseases
21 Aug 2024
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
Individuals with type 2 diabetes (T2D) treated in routine clinical care appear to fare better with glucagon-like peptide-1 receptor agonists (GLP-1RAs) than with dipeptidyl peptidase-4 inhibitors (DPP-4is), with GLP-1Ras being associated with lower rates of hyperkalemia and renin-angiotensin system inhibitor (RASi) medication discontinuation, as shown in an observational study.
